These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 24316517)

  • 1. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
    Vrieze A; Out C; Fuentes S; Jonker L; Reuling I; Kootte RS; van Nood E; Holleman F; Knaapen M; Romijn JA; Soeters MR; Blaak EE; Dallinga-Thie GM; Reijnders D; Ackermans MT; Serlie MJ; Knop FK; Holst JJ; van der Ley C; Kema IP; Zoetendal EG; de Vos WM; Hoekstra JB; Stroes ES; Groen AK; Nieuwdorp M
    J Hepatol; 2014 Apr; 60(4):824-31. PubMed ID: 24316517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of amoxicillin and vancomycin on parameters reflecting cholesterol metabolism.
    Baumgartner S; Reijnders D; Konings MCJM; Groen AK; Lütjohann D; Goossens GH; Blaak EE; Plat J
    Chem Phys Lipids; 2017 Oct; 207(Pt B):239-245. PubMed ID: 28647339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
    Murphy EF; Cotter PD; Hogan A; O'Sullivan O; Joyce A; Fouhy F; Clarke SF; Marques TM; O'Toole PW; Stanton C; Quigley EM; Daly C; Ross PR; O'Doherty RM; Shanahan F
    Gut; 2013 Feb; 62(2):220-6. PubMed ID: 22345653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial.
    Reijnders D; Goossens GH; Hermes GD; Neis EP; van der Beek CM; Most J; Holst JJ; Lenaerts K; Kootte RS; Nieuwdorp M; Groen AK; Olde Damink SW; Boekschoten MV; Smidt H; Zoetendal EG; Dejong CH; Blaak EE
    Cell Metab; 2016 Jul; 24(1):63-74. PubMed ID: 27411009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Microbiota Manipulation and Forearm Substrate Metabolism in Obese Men: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Reijnders D; Goossens GH; Hermes GDA; Smidt H; Zoetendal EG; Blaak EE
    Obes Facts; 2018; 11(4):318-326. PubMed ID: 30089301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota composition modifies fecal metabolic profiles in mice.
    Zhao Y; Wu J; Li JV; Zhou NY; Tang H; Wang Y
    J Proteome Res; 2013 Jun; 12(6):2987-99. PubMed ID: 23631562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
    de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M
    Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
    Han JL; Lin HL
    World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects.
    Bouter K; Bakker GJ; Levin E; Hartstra AV; Kootte RS; Udayappan SD; Katiraei S; Bahler L; Gilijamse PW; Tremaroli V; Stahlman M; Holleman F; van Riel NAW; Verberne HJ; Romijn JA; Dallinga-Thie GM; Serlie MJ; Ackermans MT; Kemper EM; Willems van Dijk K; Backhed F; Groen AK; Nieuwdorp M
    Clin Transl Gastroenterol; 2018 May; 9(5):155. PubMed ID: 29799027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity.
    Hwang I; Park YJ; Kim YR; Kim YN; Ka S; Lee HY; Seong JK; Seok YJ; Kim JB
    FASEB J; 2015 Jun; 29(6):2397-411. PubMed ID: 25713030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.
    Canfora EE; van der Beek CM; Hermes GDA; Goossens GH; Jocken JWE; Holst JJ; van Eijk HM; Venema K; Smidt H; Zoetendal EG; Dejong CHC; Lenaerts K; Blaak EE
    Gastroenterology; 2017 Jul; 153(1):87-97.e3. PubMed ID: 28396144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laxative treatment with polyethylene glycol decreases microbial primary bile salt dehydroxylation and lipid metabolism in the intestine of rats.
    van der Wulp MY; Derrien M; Stellaard F; Wolters H; Kleerebezem M; Dekker J; Rings EH; Groen AK; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G474-82. PubMed ID: 23868407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity.
    Verdam FJ; Fuentes S; de Jonge C; Zoetendal EG; Erbil R; Greve JW; Buurman WA; de Vos WM; Rensen SS
    Obesity (Silver Spring); 2013 Dec; 21(12):E607-15. PubMed ID: 23526699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.
    Islam KB; Fukiya S; Hagio M; Fujii N; Ishizuka S; Ooka T; Ogura Y; Hayashi T; Yokota A
    Gastroenterology; 2011 Nov; 141(5):1773-81. PubMed ID: 21839040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.
    Mikkelsen KH; Frost M; Bahl MI; Licht TR; Jensen US; Rosenberg J; Pedersen O; Hansen T; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    PLoS One; 2015; 10(11):e0142352. PubMed ID: 26562532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term ingestion of difructose anhydride III (DFA III) on intestinal bacteria and bile acid metabolism in humans.
    Minamida K; Asakawa C; Sujaya IN; Kaneko M; Abe A; Sone T; Hara H; Asano K; Tomita F
    J Biosci Bioeng; 2006 Feb; 101(2):149-56. PubMed ID: 16569611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.
    Vrieze A; Van Nood E; Holleman F; Salojärvi J; Kootte RS; Bartelsman JF; Dallinga-Thie GM; Ackermans MT; Serlie MJ; Oozeer R; Derrien M; Druesne A; Van Hylckama Vlieg JE; Bloks VW; Groen AK; Heilig HG; Zoetendal EG; Stroes ES; de Vos WM; Hoekstra JB; Nieuwdorp M
    Gastroenterology; 2012 Oct; 143(4):913-6.e7. PubMed ID: 22728514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
    Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL
    Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women.
    Alemán JO; Bokulich NA; Swann JR; Walker JM; De Rosa JC; Battaglia T; Costabile A; Pechlivanis A; Liang Y; Breslow JL; Blaser MJ; Holt PR
    J Transl Med; 2018 Sep; 16(1):244. PubMed ID: 30176893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.